Evolus, Inc. (EOLS) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-03-04 02:42:13 ET
Evolus, Inc. (EOLS) Q4 2025 Earnings Call March 3, 2026 4:30 PM EST
Company Participants
Nareg Sagherian - Head of Global Investor Relations & Corporate Communications
David Moatazedi - President, CEO & Director
Tatjana Mitchell - Chief Financial Officer
Rui Avelar - Chief Medical Officer and Head of Research & Development
...
Read the full article on Seeking Alpha
For further details see:
Evolus, Inc. (EOLS) Q4 2025 Earnings Call Transcript
Evolus Inc.
NASDAQ: EOLS
EOLS Trading
2.85% G/L:
$5.37 Last:
398,630 Volume:
$5.54 Open:
EOLS Latest News
EOLS Stock Data
$288,448,039
43,258,131
1.1%
49
N/A
Pharmaceuticals
Healthcare
US
Newport Beach
